高级检索
当前位置: 首页 > 详情页

A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology [2]Swedish Orphan Biovitrum [3]Swedish Orphan Biovitrum Research Site,Beijing,China [4]Swedish Orphan Biovitrum Research Site,Chongqing,China [5]Swedish Orphan Biovitrum Research Site,Hefei,China [6]Swedish Orphan Biovitrum Research Site,Wuhan,China

关键词: rare diseases fumarylacetoacetate hydrolase (FAH) deficiency liver failure drug treatment nitisinone observational research phase IV China pediatric patient

研究目的:
This is a prospective, non-interventional, non-comparative, multicenter study to collect data on HT-1 patients in China treated with Nitisinone in a routine clinical setting. No tests or examinations are mandated in the study.

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)